183872-16-4

Upstream product

• 183872-14-2 1,1-ethylenedioxy-3-[(E)-3-hydroxy-7-phenyl-1-hepten-1-yl]cyclohexane 
• 65005-14-3 1,4-dioxa-spiro[4.5]decane-7-carbaldehyde 
• 37722-82-0 methyl 3-hydroxycyclohexanecarboxylate 
• 21531-47-5 3-oxo-cyclohexanecarboxylic acid methyl ester 
• 13149-16-1 methyl 1,4-dioxaspiro[4.5]decane-7-carboxylate 

Downstream Products

• 183872-18-6 3-[(E)-3-tert-butyldimethylsilyloxy-7-phenyl-1-hepten-1-yl]cyclohexanone 
• 257866-67-4 3-[(E)-3-fluoro-7-phenyl-1-hepten-1-yl]cyclohexanone 
• 257866-98-1 methyl (E)-3-[(E)-3-hydroxy-7-phenyl-1-hepten-1-yl]cyclohexylidene acetate 

Relevant academic research and scientific papers

Synthesis and structure-activity relationships of new 1,3- disubstituted cyclohexanes as structurally rigid leukotriene B4 receptor antagonists

A series of 1-hydroxy-3-[3-hydroxy-7-phenyl-1-hepten-1-yl] cyclohexane acetic acid derivatives was designed based on postulated active conformation of leukotriene B4 (LTB4) and evaluated as human cell surface LTB4 receptor